QIAGEN, a biotechnology company located in Germantown, is planning to expand its facilities.
As part of its expansion, QIAGEN has reportedly hired 80 additional workers to the Germantown site and $7 million into new building renovations and equipment. The company’s growth comes after a surge of business since the start of the pandemic. QIAGEN develops and provides products that are used to make COVID-19 research to make testing more efficient.
“We are proud to support the important work that QIAGEN is doing right here in Maryland to help in the fight against COVID-19,” said Governor Larry Hogan.
QIAGEN’s expansion plans only add to Montgomery County’s thriving biotech industry. With the FDA and NIH both being in Montgomery County, the County has become a premier location for many companies. Benjamin H. Wu, president & CEO of the Montgomery County Economic Development Corporation (MCEDC), expressed proudly, “QIAGEN’s expansion reinforces Montgomery County’s strength as the immunology capital next to the nation’s capital.”
Photo courtesy of QIAGEN’s website.